Journey Medical Corporation
USD6.06
+0.04 (+0.66%)
CEO
Claude Maraoui
IPO Date
2021-11-12
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$5.98
Prev. Close
$6.02
Day Low
$5.88
Day High
$6.19
52W Low
$4.31
52W High
$9.55
Market Cap
$0.17B
Volume
0.18M
| 62,795 |
| $5.04 |
| 24 Apr 2026 | Benesch Joseph | CFO | A-Award | Acquired | 28,907 | $0.00 |
| 24 Apr 2026 | Benesch Joseph | CFO | A-Award | Acquired | 41,860 | $5.04 |
| 24 Apr 2026 | Maraoui Claude | director, officer: President & CEO | A-Award | Acquired | 49,277 | $0.00 |
| 24 Apr 2026 | Maraoui Claude | director, officer: President & CEO | A-Award | Acquired | 82,915 | $5.04 |
| 26 Aug 2025 | Maraoui Claude | director, officer: President & CEO | M-Exempt | Acquired | 1,250,000 | $0.07 |
| 26 Aug 2025 | Maraoui Claude | director, officer: President & CEO | F-InKind | Disposed | 10,877 | $7.47 |
| 26 Aug 2025 | Maraoui Claude | director, officer: President & CEO | M-Exempt | Disposed | 1,250,000 | $0.07 |
| 7 Aug 2025 | ROSENWALD LINDSAY A MD | director | A-Award | Acquired | 50,000 | $0.00 |